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ABSTRACT 
We have proposed in the previous study that the NON mouse is an 
animal model suitable f or study ing human non-obese, non-insulin-
dependent diabetes mellitus, and we have shoHn that hypo-
insulinemia in the NO� mouse Has associated Hith reduced levels 
of insulin mRNA in their pancreas. These results suggest that 
structural alternation of the insulin gene may occur in this 
mouse. In the present study , to corroborate this possibility , He 
attempted to isolate and characte�ize the insulin gene of the 
NON mouse. Comparison Hi th structures of the insulin I and II 
genes of the BALB/c mouse demonstrated that the NON mouse has 
tHo non-allelic insulin genes, encoding separately insulin I and 
II. The nucleotide sequences of the NON mouse insulin genes, 
including 5 '-transcriptional regulatory region and exon/intron 
organization, do not dif f er f rom the reported sequences of the 
insulin I and II genes of the BALB/c mouse. We can, hoHever, 
point out that about 100 base pairs additional sequence and 7 
point mutations are involved in f urther upstream 5 '-f lanking 
region of , and 3 point mutations in 3' -f lanking region of the 
insulin II gene of the NON mouse. We concl ude that the reduced 
expression of the insulin genes in the NON mouse i s  due to 
neith er the structural change in the known transcriptional 
regulatory elements nor occurrence of the abnormal and unstable 
insulin mRNA. Role of the 5' -upstream additional sequence for 
the insulin II gene expression remains to be elucidated. 
INTRODUCTION 
Diabetes mellitus is not a single disease but a group of hetero-
geneous disorders with common features due to deficiency of 
insulin action(World H ealth Organization, 1985). Non-insulin-
dependent diabetes mellitus (NIDDi"') is one of major types of 
diabetes mellitus. NIDDM is expected from several clinical 
findings to have a strong genetic basis in addition to environ-
mentally ·affected conditions. Its exact pathogenesis, however, 
remains to be elucidated, because of the difficulty to clarify 
extent of contribution of both factors to an individual case of 
NIDDM(Rossini, Mordes & H andler, 1988). 
The ·NoN mouse is a subline separated from the Jcl-ICR mouse 
in the course of isolation of the NOD mouse that is known as an 
animal model for insulin-dependent diabetes mellitus (IDDM) 
(Makino, Kunimoto, Muraoka et al. 1980; Tochino, 1986). In the 
previous study, we have characterized the NON mouse as follows; 
(1)no obesity, (2)glucose intolerance but not overt diabetes, 
( 3 )hypoinsulinemia, ( 4) no pathological findings including auto-
immune changes in pancreatic islets and the thyroid gland. These 
characteristics appear to be similar to those of non-obese human 
NIDDM, we have proposed that the NON mouse is an animal model 
sui table for studying non-obese human NIDDM ( Ohgaku, Morioka, 
Sawa et al. 1988). Therefore, we anticipate that the study using 
the NO mouse will be a major breakthrough to clarify the 
pathogenesis of NIDDM. Furthermore we have demonstrated the 
remarkably reduced l evels of both insulin and preproinsul in mRNA 
in pancreas of the NO - mouse. In the analysis of restriction 
fragment length poly morphism ( RFLP) of insulin gene in the NON, 
NOD, and Jcl-ICR mouse, we have observed an extra and 1--1eak 
s i g n a l  o n l y  in t h e  ���til- treated gen o m ic DNA of t h e  N ON 
mouse(Ohgaku et al. 1988). From these resul ts, we suggested that 
glucose intolerance in the NON mouse results from the reduced 
expression of the insulin gene which may have an altered 
structure especially in the transcriptional regulatory region. 
In the present study , we isolated two non-allelic insulin genes 
from the NON mouse, determined their nucleotide sequences, and 
discussed about their features. 
MATERIALS AND METH ODS 
Animal strains. 
0 mice were provided from Sh ionogi Research Laboratori es, 
Osaka, Japan. 
Materials. 
1·-Lauroylsarcosine, sodium salt, was obtained from Sigma, 
St Louis, MO, U.S. A. Proteinase K was from Merck, Darmstadt, 
F.R.G. a-32P]dCTP (111 TBq/mmol) was purchased from ICN 
Chemicals, Irvine, CA, U.S.A. , and [ a-35s]dATP (24.1 TBq/mmol) 
was purchased from Amersham International plc, Amersh am, Bucks, 
U. K. Deoxy ribonuclease I was from Pharmacia LKB Biotechnology 
AB, Upsala, Sweden. Mboi and !i§_iKl were from New England 
Biolabs, Beverly , MA, U. S. A. Oth er restriction endonucleases, 
D A modify ing enzy mes were from NIPPON GENE, Toy ama, Japan. Rat 
preproinsulin I eDNA was a generous gift from Dr. H iroshi 
Okamoto, Department.of Bioch emistry , Toh oku University School of 
Med i c i n e, Japan, who cloned and a n a l y z e d  i t s  s e q u e n c e  ( 
unpublished data ) . 
Extraction of high-molecular-weight DNA. 
H igh -molecular-weigh t genomic DNA was isolated from th e mouse 
liver as described elsewhere (Cox, Damjanov, Abanob i  et al. 
1973) with sligh t modifications. After sacrifice of animal, 
liver was immediately excised and rinsed in 0. 9% (w/v) NaCl. 
About 1 g of the tissue was put into ny lon mesh (sample pack; 
EIKEN, Toky o, Japan), immersed in 7 ml of ice-cold 0.5 M EDTA, 
( pH 8.0) and squashed gently with the blunt end of a spatula on 
ice. Liver cells were suspended in 10 ml of 0. 5 M EDTA, pH 8.0, 
in a 50 ml Falcon poly propy lene tube ( #2070), and ly sed by 
addition of 0.1 rnl of 10 mg/ml proteinase K and 0.25 ml of 20% 
(w/v) sodium Lauroy l sarcosinate. After overnight incubation at 
50°Ct DNA was extracted 3 times with phenol/chloroform/isoamy l 
alcohol (25: 24: 1, v/v), and subjected to dialy sis until OD270 of 
the dialy sate is less than 0. 05. 
Construction of the genomic library of the NON mouse. 
After partial digestion of high molecular weight genomic DNA 
with Mbol, DNA fragments having the sizes of about 20 kilobase 
pairs ( kbp) were isolated by sucrose gradient ul tracentrifuga-
t ion , l i ga t e d  with t h e  �.§:..!B.!:!. I-t reate d L a m b d a  Dash a r m s  
(Stratagene, San Diego, CA, U.S. A.) an d assembled into phage 
using the in vitro packaging kit (Arnersham) by a standard pro-
tocol(Maniatis, 1982). 
Isolation and subcloning of the genes encoding insulin I and II 
from the genomic library of the NON mouse. 
Using the nick-translated rat preproinsulin I eDNA as a probe, 
approximately 6 X 105 phages of the amplified genomic library 
was screened by plaque hy bridization (Benton & Davis, 1977) with 
slight modification as follows: nitrocellulose replicas were 
incubated at 45o C ov ernight with prehy bridizing solution 
containing 50% (v/v) deionized formarnide, 50 mtvl Tris-H Cl ( pH 
8. 0), 1 M aCl, 0. 1% (w/v) sodium dodecy l sulfate (SDS), 5 mM 
EDTA, 4 rnM sodium phosphate, 5x Denhardt's solution (1x is 0. 02% 
(w/v) poly viny lpy rrolidone, 0. 02% (w/v) Ficoll, 0. 2% (w/v) 
bovine serum albumin), and 200 �g of sonicated, heat-denatured 
salmon testes D A/ml. They were then hy bridi�ed with the probe 
in the solution at 45oc for 24 h, and washed at 45°C in a 
solution containing 10 mM Tris-H Cl (pH 8. 0), 25 mM NaCl, 0.1% 
SDS, 1 rnM EDTA, 1 mM sodium phosphate, and 1x Denhardt's 
solution for 6 h with several changes of the washing solution. 
Phage DN A w a s  prepared by g l y c e r o l  s t e p  g r a d i e n t  
centrifugation(Maniatis, 1982) and digested with ��QRl a nd 
BamH I. After agarose gel electrophoresis, phage DNA was trans� 
ferred to nitrocellulose filter. The filter was hy bridized to 
rat preproinsulin I eDNA probe as described above. DNA fragment 
containing putative preproinsulin gene were subcloned into 
B lu e s c r i p t  KS ( +) plasmid ( Stratage n e ,  San D i ego). T h e  
recombinant plasmid was propagated in Escherichia coli MC1061, 
and isolated by alkaline ly sis and poly ethy lene gly col preci­
pitation(Brush, Dodgson, Choi et al. 1985). 
Construction of deletion mutants and nucleotide sequence deter-
ruination. 
Plasmid carry ing the genomic DNA in both orientations were 
isolated and subjected to preparation of serial deletion mutants 
according to the method of Henikoff ( 1984). The appropriately 
deleted inserts were selected and sequenced by the dideoxy chain 
termination method( Sanger, Nicklen & Coulson, 1977). Sy nthetic 
primers complementary to T3 and T7 promoter sequences, alkali-
denatured plasmid DNAs, and [a-35s] dATP were used in the 
reaction. 7-Deaza-dGTP (Boehringer Mannheim GmbH, Mannheim, 
F.R.G.) was used instead of dGTP in the sequencing to avoid the 
secondary structure problems. 
RESULTS 
After the screen in g, we obtain ed 5 positive clon es. We subjected 
these clon es to Southern an aly sis usin g the radioactive cD �A 
probe. On e clon e, A in s-I, showed 3 �coRI fragmen ts an d a 1.4-
kbp fragmen t was hy bridized with the probe. I n  the BamH I-
-----
digestion, this clon e showed a 5. 3-kb fragmen t, which was formed 
from the in tern al BamH I sites, an d this fragmen t was hybridized. 
An other, ANin s-II, display ed a 2. 5-kb BamH I fragmen t, an d this 
fragmen t was hy bridized with the eDNA probe ( Fig. 1). From the 
comparison of restriction maps of the BALB/c mouse preproin sulin 
I an d II gen es(Wen tworth, Schaefer, V illa- Komaroff et al. 1986), 
we suggested that A Nin s-I an d A Nin s-II clon es carry putative 
NON mouse preproin sulin I an d II gen es respectively . 
For further restriction mappin g an d sequen cin g an aly sis, we 
con structed plasmid subclon es: pNin s-I for the 1.4-kb EcoRI 
-----
fragmen t from A Nin s-I, an d pNin s-II with the 2.5-kb BamH I frag-
men t from A Nin s-II. The restriction maps an d sequen cin g 
strategies for the NON mouse pNin s-I an d II subclon es are shown 
in Fig. 2. 
Figure 3 shows the n ucleotide an d deduced amin o acid 
sequen ces of the p in s-I. Comparin g with the preproin sulin I 
gen e of the BALB/c mouse, we s uggested that putative tran s-
cription initiation site was present at A of position 648. 
Sequences for exon 1 (position 648 to 693), exon 2 (812 to 1209) 
including polyadenylation signal (position 1190), intron. (694 to 
811), were identical to that of the BALB/c mouse preproinsulin I 
gene. Thus, pNins-I encodes the NON mouse preproinsulin I gene. 
The 5' -flanking sequence (position 1 to 647) was identical to 
that of the BALB/c mouse preproinsulin I gene. This region 
includes general promoter and enhancer elements: the TATA box 
(position 624-629), the CAAT box (position 579-588), enhancer 
core sequence (position 339-345), and also the beta cell-
specific enhancer elements: "Nir box ", and " Far box" like 
sequences (positions 542-549 and 416-423, respectively) as pre-
vi o us l y reported ( Karlsson , Edlund , M o s s �1. §:.l . 1 9 8 7 ) . The 
sequence for 3'-flanking region was also identical with that of 
the BALB/c mouse preproinsulin I gene. 
The structure of the pNins-II is shown i n  Fig. 4. The 
putative transcription initiation site was present at A of 
position 1061. Sequences for exbn 1 (position 1061 to 1106), 
exon 2 ( 1225 to 1427), and exon 3 ( 1916 to 2115) including the 
polyadenylation signal (position 2096), and intron 1 (position 
1107 to 1224), and intron 2 (1428 to 1915) were all identical to 
the reported structures of the BALB/c mouse preproinsulin II 
gene. Thus, p ins-II encodes the NON mouse preproinsulin II 
gene. The 5'-transcriptional regulatory region (from trans-
cription initiation site to about 350bp upstream) Has identical 
with that of the BALB/c mouse preproinsulin II gene. But further 
upstream, near the BamHI subcloning site, 7 point mutations Here 
found: 5 insertions at position 156, 237, 264, 361 and 374, 1 
substitution at 315, 1 deletion at between 124 and 125. And from 
1 to 113 (1061bp to 948bp upstream of transcriptional initiation 
site), the NON mouse preproinsulin II gene had 113bp additional 
sequence was not reported in the BALB/c mouse preproinsulin II 
gene. Three point mutations were also found in the 3'- flanking 
region: 1 insertion at 2495, 1 substitution at 2365, 1 deletion 
at between 2391 and 2392. 
Furthermore, as would be expected from these results, the 
deduced amino acid sequences of the NON mouse preproinsulins I 
and II were identical with those of BALB/c mouse preproinsulins 
I and II, respectively. 
DISCUSSION 
In the previous studies, He have presented that the NON 
mouse is an animal model suitable for studying non-obese human 
NIDDM. Furthermore, from the evidence for the reduced level of 
preproinsulin mRNA in the pancreas of the NON mouse, we have 
proposed a hypothesis that glucose intolerance in the 70N mouse 
is caused by the reduced synthesis of insulin due to possible 
defect(Ohgaku et al. 1988). Several responsible sites of defects 
may be possible: gene defects, reduced mRNA stability due to 
changes in the exon/intron organization, the abnormalities of 
splicing in maturation of mRNA, and decrease in transcriptional 
efficiency due to an altered structure in cis- or trans-acting 
factors. 
In this study, we have shown that the NON mouse has two 
non-allelic preproinsulin genes, I and I I,  and that their 
exon/intron organizations are identical to those of the BALB/c 
mouse. Thus, we exclude possibilities of gene defects and of 
changes in the exon/intron organization. 
Several cases of human diabetes, induced by the abnormal 
insulin due to the point mutation of insulin gene, have been 
reported (Kwok, Steiner, Rubenstein et al. 1983; Haneda, Chan, 
Kwok et al. 1983; Nanjo, Sanke, �Iiyano et al. 1986). In the 
prelimin ary study, we have observed that the NON mouse in sulin I 
and II proteins are identical with those of n ormal Jcl-ICR mouse 
with reversed-phase high-performance liquid chromatography 
(HPLC)(data not shown). Further con firmation of the results was 
obtained from the present study, Hhere no substitutions 1-1ere 
observed in the deduced amino acid sequences of 1-0 - mouse 
in sulin I and II (Figs. 3 an d 4). 
In mammals, insulin gene expression is restricted to beta 
cells of the pancreatic islet. The cis- actin g region s of the rat 
insulin genes have been located within about 350 bp of their 5'-
flanking region ; 5'-transcription al regulatory region(Walker, 
Edlun d, Boulet et al. 1983; Hanahan 1985). Two cell-specific 
regulatory elemen ts, an enhancer an d a promoter, appear to be 
operative in this region . Recen t reports have demon strated that 
reductions of insulin gen e expression result from mutations in 
these elements(Karlsson et al. 1987, Crowe & Tsai, 1989; Hwun g, 
Crowe, Peyton et al. 1989). From these studies, it was possible 
that mutations in 5'-tran scription al r egulatory region can 
reduce expression of the in sulin gene in the NON mouse. In deed 
our RFLP study of NON mouse preproinsulin gene has demonstrated 
that NON mouse preproin sulin gene has a unique RFLP in the 
BamHI-digested DNA, which seemed to offer in direct eviden ce for 
this possibility. In this study, we observed no structural 
change in the known 5' -transcriptional regulatory elements in 
both NON mouse preproinsul in genes. Accordingly, the reduced 
expression of NON mouse preproinsulin genes is not the result of 
the mutation in these elements. S ince the NON mouse has no 
internal BamHI site in preproinsulin I and II genes, the 1. 7-kb 
extra band with weak intensity observed in the NON mouse is 
false positive. 
Several mutations are found in the further 5'-upstream 
f l a n k i n g  r eg i o n  and 3' - f l a n k i n g  r e g i o n. E s p e c i a ll y ,  a n  
additional 5'-flanking sequence which is not reported i n  BALB/c 
mouse calls our attention. This sequence seems to be similar to 
p6lymorphic region as reported in human insulin gene(Bell, Karam 
& Rutter; 1981; Bell, Selby & Rutter, 1982) and in rat prepro-
insulin I gene (Winter, Beppu, Maclaren et al. 1987). The rela-
tionship between the length of polymorphic region of insulin 
gen e  a n d  t h e  occur r e n c e  o f  d i a b et e s  i n  h u m a n  h a s  b e e n  
discussed(Bell, Horita & Karam, 1984; Rotwein, Chyn, Chirgwin et 
al. 1981). But this pol ymorphic region is reported not to be 
essential for insulin gene expression (Hanahan, 1985) and does 
not have functional role for overall insulin secretion(Perrnutt, 
Rotwein, Andreone et al. 1985). The poss ibility of the poly-
morphic region of preproinsulin gene to function as a cis-acting 
f a c t o r s, h ow e v er ,  h a s  n o t  b ee n  ent i r e l y  e x c l u d e d  i n  
human ( Takeda, Ishii, Seino et al. 1989). I n  rat, it has been 
d e m o n s t r a t e d t h a t  negative t r a n s c r i p t i o n a l  r e g u l a t ory 
"silencer" ) element is present betHeen 2. 0 and 4. 0 kbp upstream 
of rat preproinsulin I sequence (Laimin s, Holmgren-Koenig & 
Khoury, 1986). It is possible that the additional 113 bp 
sequence .is a "silencer" element. To elucidate this possibility, 
it is important to knoH the aff ected component of the tHo 
insulin proteins in the NON mouse. Thereafter, expression study 
using the reported additional region is needed. element or not. 
We also found 3 point mutations in the 3'-flanking region 
of preproinsulin II gene. From previous studies (Walker et al. 
1983; Hanahan 1985), 3'-flanking region of the insulin gene does 
n o t  a p p e a r  t o  h av e  t h e  e n h a n c e r  activi t i e s  t o  t h e  g e n e  
expression. We need, however, to examine enhancer activities in 
this region and effect of 3 mutations. Furthermore, He cannot 
exclude possibilities that abnormalities of the splicing or an 
altered structure in trans-acting factor takes part in reduced 
expr e s s i o n  o f  t h e  i n s u l in gene e x p r e s sion a n d  g l u c o s e  
intolerance in the NON mouse. Thus, we need to elucidate these 
possibilities in further study. 
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Legends for Figures 
Figure 1: 
Electrophoresis and Northern blot analy sis for genomic clones 
�Nins-I and �Nins-II. The �Nins-I digested with EcoRI(lane 1) 
or BamHI(lane 2), and the �Nins-II digested with BamHI(lane 3) 
are analy zed by electrophoresis o n  0. 8 percent agarose gel, 
which was stained with ethidium bromide, and then photographed 
under UV illumination. lanes 4, 5 and 6 are the analy sis of lane 
1, 2 and 3, respectively , by Northern blot hy bridization using 
ra� preproinsulin I eDNA probe. Molecular size markers are 
indicated in kbp on the left side of the figure. 
Figure 2: 
Restriction maps and sequencing strategies of the subclones 
pNins-I ( §:.) and pNins-I I ( 12_) • Nucleotide numbers are given at 
the !:.Qp_. The deduced restriction endonuclease sites are shown. 
Exons are indicated by solid boxes. Horizontal arrows indicate 
the sequencing strategy . 
Figure 3: 
Nucleotide and deduced amino acid sequence of NON mouse prepro-
insulin I gene. Capital letters indicate exons and lowercase 
letters are used for intron and 5'- and 3'- flanking sequences. 
The number of nucleotide residues is indicated at the end of 
each line. The deduced amino acid sequence is given below the 
nucleotide sequence. Stop codon is indicated by "***" The 
sequences of putative promoters, enhancers and the poly A signal 
are underlined. 
Figure 4: 
Nucleotide and deduced amino acid sequence of NON mouse prepro-
insulin I I gene. Capital letters, lowercase letters, and the 
numbering of nucleotide residues are used as described in Fig. 2. 
The deduced amino acid sequence is given below the nucleotide 
s e qu e n c e .  S t o p  c o d o n  i s  i n d i c a t e d  b y  "***" N u c l e o t i d e  
differences found in the BALB/c sequence are displayed beneath 
the NON mouse sequence, and indicated by ���iiQ�l ���Q��· 
Deletions are indicated by dashes. The sequences of putative 
promoters, enhancers and the poly A signal are underlined. 
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